BioRestorative Therapies Common Stock (NV) (BRTX) Q3 2024 Earnings

14AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-1.55
-1.03
-0.52
0

Details

Expected EPS
-0.57
Actual EPS
-0.5
Surprise EPS
0.07
Surprise Percent
+12.28%

Description

BioRestorative Therapies Common Stock (NV) (BRTX) has reported earnings of -0.5 per share for Q3 2024.

0 Comments

Share your thoughts